| Date Filed | Type | Description |
| 05/23/2023 |
4
| McCarthy Sean A. (CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Exercised 16,535 options to buy
@ $1.5749, valued at
$26k
|
|
| 03/20/2023 |
4
| McCarthy Sean A. (CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 7,121 shares
@ $1.8805, valued at
$13.4k
|
|
| 02/06/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/26/2021 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $5.34, valued at
$534k
Granted 80,000 options to buy
@ $0 |
|
| 08/13/2021 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Exercised 92,113 options to buy
@ $1.1339, valued at
$104.4k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/28/2020 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Exercised 100,000 options to buy
@ $1.1339, valued at
$113.4k
|
|
| 12/07/2020 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 930 shares
@ $6.392, valued at
$5.9k
|
|
| 09/23/2020 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Exercised 20,500 options to buy
@ $6.6147, valued at
$135.6k
|
|
| 06/02/2020 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 1,158 shares
@ $5.1085, valued at
$5.9k
|
|
| 05/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2019 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 1,080 shares
@ $5.321, valued at
$5.7k
|
|
| 06/04/2019 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 695 shares
@ $8.211, valued at
$5.7k
|
|
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/06/2018 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 468 shares
@ $11.73, valued at
$5.5k
|
|
| 09/06/2018 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 13,052 shares
@ $21.862, valued at
$285.3k
Exercised 13,052 options to buy
@ $1.5749, valued at
$20.6k
|
|
| 07/09/2018 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 4,497 shares
@ $25.0586, valued at
$112.7k
Exercised 4,497 options to buy
@ $1.5749, valued at
$7.1k
|
|
| 07/06/2018 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 2,028 shares
@ $25.089, valued at
$50.9k
Exercised 2,028 options to buy
@ $1.5749, valued at
$3.2k
|
|
| 07/03/2018 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 13,052 shares
@ $23.4223, valued at
$305.7k
Exercised 13,052 options to buy
@ $1.5749, valued at
$20.6k
|
|
| 06/05/2018 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 302 shares
@ $17.901, valued at
$5.4k
|
|
| 05/02/2018 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 19,578 shares
@ $26.5473, valued at
$519.7k
Exercised 19,578 options to buy
@ $1.5749, valued at
$30.8k
|
|
| 03/05/2018 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 19,578 shares
@ $29.428, valued at
$576.1k
Exercised 10,516 options to buy
@ $1.5749, valued at
$16.6k
Exercised 9,000 options to buy
@ $1.1339, valued at
$10.2k
Exercised 62 options to buy
@ $0.945, valued at
$58.6 |
|
| 02/12/2018 |
5
| McCarthy Sean A. (President and CEO) has filed a Form 5 on CytomX Therapeutics, Inc. |
| 01/26/2018 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $25.82, valued at
$7.7M
|
|
| 01/09/2018 |
4
| McCarthy Sean A. (President and CEO) has filed a Form 4 on CytomX Therapeutics, Inc.|
Txns:
| Sold 6,526 shares
@ $25.01, valued at
$163.2k
Exercised 6,526 options to buy
@ $1.1339, valued at
$7.4k
|
|
|